Martin Stogniew

Martin Stogniew

UNVERIFIED PROFILE

Are you Martin Stogniew?   Register this Author

Register author
Martin Stogniew

Martin Stogniew

Publications by authors named "Martin Stogniew"

Are you Martin Stogniew?   Register this Author

14Publications

358Reads

17Profile Views

Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.

Cancer Cell 2019 May 2;35(5):721-737.e9. Epub 2019 May 2.

The University of Texas MD Anderson Cancer Center, Molecular Hematology and Therapy, Department of Leukemia, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center; Department of Leukemia, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.03.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620028PMC
May 2019

Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.

Cell Cycle 2017 Oct 10;16(19):1790-1799. Epub 2017 May 10.

a Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2017.1325046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628644PMC
October 2017

Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibiotic.

J Clin Pharmacol 2008 Sep 16;48(9):1063-8. Epub 2008 Jul 16.

Vicuron Pharmaceuticals, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270008321273DOI Listing
September 2008

Pharmacokinetics and tissue distribution of anidulafungin in rats.

Antimicrob Agents Chemother 2008 Jul 28;52(7):2673-6. Epub 2008 Apr 28.

Pfizer Inc., New York, New York 10017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01596-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2443878PMC
July 2008

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

J Clin Pharmacol 2007 Mar;47(3):305-14

Clinical Pharmacology, Pfizer Global Research & Development, 685 3rd Avenue, New York, NY 10017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270006296764DOI Listing
March 2007

Pharmacokinetics and excretion of dalbavancin in the rat.

J Antimicrob Chemother 2005 Mar;55 Suppl 2:ii31-5

Vicuron Pharmaceuticals Italy, Via R. Lepetit 34-21040, Gerenzano, Varese, Italy.

View Article

Download full-text PDF

Source
http://academic.oup.com/jac/article/55/suppl_2/ii31/2473418/
Publisher Site
http://dx.doi.org/10.1093/jac/dki006DOI Listing
March 2005

Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine.

J Clin Pharmacol 2005 Feb;45(2):227-33

Pharmacokinetics and Pharmacology, Vicuron Pharmaceuticals, 455 South Gulph Road Suite 310, King of Prussia, PA 19406, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270004270146DOI Listing
February 2005